Company: BCAR
Filing Date: 2025-04-29
Form Type: S-1
Source: 0001829126-25-003006
Chunk: 117

Company: D. Boral ARC Acquisition I Corp.
Filing Date: 2025-04-29
Form: S-1
Chunk 117
---
 New ARC could face significant adverse consequences. Please see “Risk Factor – Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions.”

Our initial shareholders paid an aggregate of $25,000, or approximately $0.002 per founder share and, accordingly, you will experience immediate and substantial dilution from the purchase of our Class A ordinary shares.

The difference between the public offering price
per share (allocating all of the unit purchase price to the Class A ordinary share and none to the warrant included in the unit) and
the pro forma net tangible book value per share of our Class A ordinary shares after this offering constitutes the dilution to you and
the other investors in this offering. Our initial shareholders acquired the founder shares at a nominal price, significantly contributing
to this dilution. Upon closing of this offering, and assuming no value is ascribed to the warrants included in the units, you and the
other public shareholders will incur an immediate and substantial dilution of approximately 106.5% (or $10.65 per share, assuming no
exercise of the underwriters’ over-allotment option), the difference between the pro forma net tangible book value per share after
this offering of $(0.65) (assuming a maximum redemption scenario) and the initial offering price of $10.00 per unit. This dilution would
increase to the extent that the anti-dilution provisions of the founder shares result in the issuance of Class A ordinary shares on a
greater than one-to-one basis upon conversion of the founder shares at the time of our initial business combination. In addition, because
of the anti-dilution protection in the founder shares, any equity or equity-linked securities issued in connection with our initial business
combination would be disproportionately dilutive to our Class A ordinary shares.

The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our sponsor is likely to make a substantial profit on its investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to materially decline.

We are offering our units at an offering price of $10.00 per unit and the amount in our trust account is initially anticipated to be $10.00 per public share, implying an initial value of $10.00 per